EUVIMEDDescoperă EUVIMED
Crossref

CRM and partial order CRM with adaptive rescaling for dose‐finding in immunotherapy trials with a continuous outcome

Pooja T Saha iD, Jason P Fine, Anastasia Ivanova iD

Statistics in Medicine · 2023

DOI: 10.1002/sim.9729 ↗

At a glance

Journal article in Statistics in Medicine, 2023. Written by Pooja T Saha and 2 co-authors. Institution: Department of Biostatistics, CB #7420, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. Major MEDLINE topics: Neoplasms. 48 references. Funded by: NCI NIH HHS, National Cancer Institute.

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

In many phase 1 oncology trials of immunotherapies, no dose‐limiting toxicities are observed and the maximum tolerated dose cannot be identified. In these settings, dose‐finding can be guided by a biomarker of response rather than the occurrences of dose‐limiting toxicity. The recommended phase 2 dose can be defined as the dose with mean response equal to a prespecified value of a continuous response biomarker. To target the mean of a continuous biomarker, we build on the idea of the continual reassessment method and the quasi‐Bernoulli likelihood. We extend the design to a problem of finding the recommended phase 2 dose combination in a trial with multiple immunotherapies.

Subjects

MeSH terms (MEDLINE)

NeoplasmsHumansMaximum Tolerated DoseMedical OncologyImmunotherapyDose-Response Relationship, DrugResearch DesignComputer Simulation

Author keywords

continual reassessment methodpartial orderphase 1 clinical trialsquasi-likelihood

Authors and institutions

  • Department of Biostatistics, CB #7420, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

ORCID profiles: Pooja T Saha, Anastasia Ivanova

Funding

  • NCI NIH HHS
  • National Cancer Institute

Cite

APA

Saha, P. T., Fine, J. P., & Ivanova, A. (2023). CRM and partial order CRM with adaptive rescaling for dose‐finding in immunotherapy trials with a continuous outcome. Statistics in Medicine. https://doi.org/10.1002/sim.9729

Vancouver

Saha PT, Fine JP, Ivanova A. CRM and partial order CRM with adaptive rescaling for dose‐finding in immunotherapy trials with a continuous outcome. Statistics in Medicine. 2023. doi:10.1002/sim.9729

BibTeX
@article{Saha2023,
  author = {Saha, Pooja T and Fine, Jason P and Ivanova, Anastasia},
  title = {CRM and partial order CRM with adaptive rescaling for dose‐finding in immunotherapy trials with a continuous outcome},
  journal = {Statistics in Medicine},
  year = {2023},
  doi = {10.1002/sim.9729}
}
Start for free →